ADMA Biologics Inc (ADMA)
6.46
-0.08
(-1.22%)
USD |
NASDAQ |
Apr 24, 16:00
6.46
0.00 (0.00%)
After-Hours: 16:28
ADMA Biologics Free Cash Flow (Quarterly): 16.19M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 16.19M |
| September 30, 2023 | 11.23M |
| June 30, 2023 | -6.931M |
| March 31, 2023 | -16.67M |
| December 31, 2022 | -11.13M |
| September 30, 2022 | -16.67M |
| June 30, 2022 | -16.77M |
| March 31, 2022 | -28.86M |
| December 31, 2021 | -37.14M |
| September 30, 2021 | -16.20M |
| June 30, 2021 | -36.74M |
| March 31, 2021 | -35.80M |
| December 31, 2020 | -35.82M |
| September 30, 2020 | -26.74M |
| June 30, 2020 | -25.45M |
| March 31, 2020 | -26.72M |
| December 31, 2019 | -21.25M |
| September 30, 2019 | -25.60M |
| June 30, 2019 | -18.76M |
| March 31, 2019 | -14.40M |
| December 31, 2018 | -19.61M |
| September 30, 2018 | -12.77M |
| June 30, 2018 | -15.41M |
| March 31, 2018 | -16.98M |
| December 31, 2017 | -15.37M |
| Date | Value |
|---|---|
| September 30, 2017 | -10.31M |
| June 30, 2017 | -8.868M |
| March 31, 2017 | -5.402M |
| December 31, 2016 | -3.624M |
| September 30, 2016 | -4.688M |
| June 30, 2016 | -4.845M |
| March 31, 2016 | -5.185M |
| December 31, 2015 | -4.074M |
| September 30, 2015 | -2.682M |
| June 30, 2015 | -4.454M |
| March 31, 2015 | -4.235M |
| December 31, 2014 | -3.459M |
| September 30, 2014 | -3.862M |
| June 30, 2014 | -4.555M |
| March 31, 2014 | -5.152M |
| December 31, 2013 | -2.965M |
| September 30, 2013 | -2.242M |
| June 30, 2013 | -2.736M |
| March 31, 2013 | -3.141M |
| December 31, 2012 | -1.842M |
| September 30, 2012 | -2.129M |
| June 30, 2012 | -1.053M |
| March 31, 2012 | -1.999M |
| December 31, 2011 | -0.0128M |
| September 30, 2011 | -0.0052M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-37.14M
Minimum
Dec 2021
16.19M
Maximum
Dec 2023
-19.78M
Average
-21.25M
Median
Dec 2019
Free Cash Flow (Quarterly) Benchmarks
| Vanda Pharmaceuticals Inc | -3.985M |
| ANI Pharmaceuticals Inc | 39.96M |
| Ligand Pharmaceuticals Inc | -42.68M |
| Puma Biotechnology Inc | 10.41M |
| Bristol-Myers Squibb Co | 3.922B |